Nutrien’s $1.31bn EBITDA masks a deeper reset in its phosphate business

Nutrien Ltd., one of the world’s largest crop-input and fertiliser companies, reported third-quarter net earnings of $288 million, down from $469 million a year earlier, while adjusted earnings before interest, tax, depreciation and amortisation reached $1.31 billion. The results, announced on November 4, 2026, were accompanied by a major portfolio decision: Nutrien will retain and optimise its principal phosphate assets rather than sell the entire business, while planning to close its higher-cost White Springs operation in Florida during the second quarter of 2027.

The Canadian company generated quarterly sales of $6.064 billion, compared with $6.007 billion in the corresponding period, but adjusted EBITDA declined from approximately $1.43 billion. Adjusted earnings per share fell to $0.61 from $0.97, highlighting the pressure on profitability despite relatively stable revenue. All dollar figures are in US dollars.

The results reveal a company confronting different economic conditions across its fertiliser businesses. Potash has benefited from strong international demand and improving selling prices, while nitrogen has faced volume challenges and phosphate production remains burdened by elevated costs. Nutrien’s latest strategic decisions suggest that improving the quality of earnings and reducing capital intensity have become as important as expanding production.

Why did Nutrien’s quarterly earnings fall despite strong global fertiliser demand?

Nutrien’s third-quarter net earnings declined by approximately 39% year on year, even as revenue increased slightly. Adjusted EBITDA fell by about 8%, reflecting the combined impact of product pricing, operational costs, sales volumes and the performance of individual business segments. The discrepancy illustrates why agricultural demand alone is an insufficient indicator of fertiliser-company profitability.

Crop nutrients operate in markets where global benchmark prices, farmer purchasing decisions, energy costs and production reliability can change margins rapidly. A producer may experience healthy demand for one nutrient while facing weaker economics in another. Nutrien’s geographically diversified operations provide exposure to several product markets, but they do not insulate the group from these differing pressures.

For the first nine months of 2026, Nutrien reported adjusted EBITDA of approximately $4.85 billion and net earnings of $1.65 billion. Potash adjusted EBITDA reached $1.97 billion, supported by strong sales volumes and higher benchmark prices, while its retail business produced approximately $1.44 billion. Nitrogen contributed $1.61 billion in adjusted EBITDA, although its performance was affected by lower sales volumes.

These nine-month results provide useful context for the weaker third quarter. Nutrien remains a substantial cash-generating agricultural supplier, but the distribution of earnings across its businesses is changing. Investors must assess whether improved performance in potash and retail can compensate for the operational and cost challenges elsewhere.

Why has Nutrien decided to close White Springs rather than sell its phosphate business?

Nutrien completed a strategic review of its phosphate operations after assessing alternatives that included potential transactions involving parts of the business. Management disclosed that it received non-binding bids but concluded that the proposals did not adequately reflect the long-term value of the assets. The company therefore chose to retain its Aurora operation and integrated upgrade facilities while planning to shut down White Springs in the second quarter of 2027.

The decision is commercially important because White Springs is approaching the end of its economically recoverable mine reserves. That situation has increased operating costs and capital requirements, making continued production less attractive. Rather than commit more capital to preserve an increasingly expensive operation, Nutrien intends to concentrate on facilities with stronger resource bases and better long-term economics.

Nutrien expects White Springs to represent approximately 20% of its phosphate sales in 2026 but around 28% of the segment’s operating cost of goods sold. That imbalance indicates why the company believes a reduction in production capacity could improve financial performance. It estimates that the planned shutdown will reduce annual sustaining capital expenditure and lease payments by approximately $50 million.

The closure has not yet occurred, and the anticipated financial benefits remain dependent on execution. Nutrien will incur shutdown-related costs and must manage the consequences for employees, customers and its remaining supply network. The company also needs to demonstrate that higher utilisation and improved product mix at retained facilities can offset the lost production contribution.

What do Nutrien’s White Springs and Trinidad asset reviews mean for future earnings?

The company’s asset decisions extend beyond phosphate. Nutrien announced an indefinite shutdown of its Trinidad nitrogen facility in October 2026 after evaluating strategic alternatives and engaging with stakeholders. Together with the White Springs plan, the action reflects an effort to reduce exposure to assets whose operating economics no longer meet management’s expectations.

There is an important accounting distinction in the company’s disclosures. Nutrien identified approximately $430 million of carrying value for assets at White Springs that will be assessed for impairment, along with $760 million of carrying value for assets at Trinidad subject to impairment evaluation. These figures represent assets under review, not final confirmed impairment charges of those amounts.

Nutrien expects to recognise expenses in the fourth quarter of 2026, including non-cash impairment charges and costs associated with severance or shutdown activities. The ultimate financial effect will depend on valuation assessments and the costs of implementing the decisions. Presenting the carrying values as completed write-offs would misrepresent the company’s financial reporting.

Strategically, the asset rationalisation could strengthen returns on capital by eliminating some production capacity that requires disproportionate expenditure. Yet such actions do not automatically create higher free cash flow, particularly during the transition period. The key measure will be whether reduced maintenance expenditure and improved margins eventually outweigh restructuring costs and the loss of sales.

Can potash demand offset weaker retail and phosphate expectations?

Nutrien raised its annual potash sales-volume guidance to between 14.3 million and 14.8 million tonnes, reflecting continuing demand in major import markets. Management also increased nitrogen sales-volume guidance to 9.3 million to 9.7 million tonnes, supported by planned improvements in reliability and production. In contrast, phosphate guidance was reduced to between 2.40 million and 2.55 million tonnes.

The company continues to forecast global potash shipments of approximately 74 million to 77 million tonnes in 2026, followed by 75 million to 79 million tonnes in 2027. These projections suggest a constructive demand environment, although they remain vulnerable to changes in crop economics, trade flows and customer purchasing patterns. Potash provides an important earnings foundation, but volume growth does not guarantee an equivalent improvement in profitability.

Nutrien also lowered its full-year retail adjusted EBITDA guidance to $1.72 billion to $1.85 billion, compared with the previous range of $1.75 billion to $1.95 billion. The reduction reflects weaker crop-nutrient margins during the third quarter. Farmer affordability, access to credit and the timing of fertiliser applications remain particularly important for the retail business.

This mixture of higher production-volume guidance and weaker earnings expectations is precisely why the group’s results require a segmented assessment. Strong potash shipments can coexist with weaker downstream margins, while planned capacity reductions can improve future efficiency without immediately raising reported profit. Investors need to follow volumes, selling prices and unit costs together rather than relying on a single market benchmark.

What must Nutrien deliver to justify its focus on cash returns?

Nutrien reported a 17% increase in cash generated from operating activities during the first nine months of 2026. It also returned approximately $1.3 billion to shareholders through dividends and share repurchases over that period, demonstrating the importance of capital distributions in its financial strategy. Management has reduced its annual capital expenditure guidance to between $1.95 billion and $2 billion.

Lower capital expenditure can improve free cash flow, but only if operating performance remains sufficiently resilient. Nutrien must balance its commitments to shareholders against the need to maintain mines, processing facilities and retail infrastructure. The White Springs and Trinidad decisions could eventually reduce recurring expenditure, although the associated transition costs remain a near-term constraint.

The shares trade under NTR in Toronto and New York, giving investors exposure to global fertiliser demand through a geographically diversified business. Market sentiment is likely to depend on whether potash strength and operating efficiencies can compensate for lower earnings in other segments. The pending impairment assessments and the pace of the White Springs shutdown are also important factors for evaluating future reported profitability.

Nutrien’s November results point to a business increasingly focused on capital productivity rather than production capacity for its own sake. Retaining higher-quality assets, reducing exposure to expensive facilities and returning cash to shareholders could produce more resilient long-term economics. The central question is whether that strategy can deliver measurably stronger free cash flow through the next agricultural cycle.